

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transport (GO:0015893) | 9.04444782 |
| 2 | organic cation transport (GO:0015695) | 8.85608315 |
| 3 | phosphate ion transport (GO:0006817) | 8.39543915 |
| 4 | lysine metabolic process (GO:0006553) | 8.19490549 |
| 5 | lysine catabolic process (GO:0006554) | 8.19490549 |
| 6 | regulation of fibrinolysis (GO:0051917) | 7.77001566 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 7.66882133 |
| 8 | negative regulation of fibrinolysis (GO:0051918) | 7.49381249 |
| 9 | omega-hydroxylase P450 pathway (GO:0097267) | 7.18451867 |
| 10 | exogenous drug catabolic process (GO:0042738) | 7.14097031 |
| 11 | quaternary ammonium group transport (GO:0015697) | 7.13482471 |
| 12 | drug catabolic process (GO:0042737) | 6.98901384 |
| 13 | phosphate ion transmembrane transport (GO:0035435) | 6.87714615 |
| 14 | complement activation, alternative pathway (GO:0006957) | 6.78336148 |
| 15 | regulation of protein activation cascade (GO:2000257) | 6.68238804 |
| 16 | cysteine metabolic process (GO:0006534) | 6.56366828 |
| 17 | urea metabolic process (GO:0019627) | 6.50328002 |
| 18 | nonribosomal peptide biosynthetic process (GO:0019184) | 6.47177462 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.22851620 |
| 20 | protein carboxylation (GO:0018214) | 6.22851620 |
| 21 | response to mercury ion (GO:0046689) | 6.20866479 |
| 22 | ethanol oxidation (GO:0006069) | 6.19671143 |
| 23 | regulation of complement activation (GO:0030449) | 6.18504652 |
| 24 | fibrinolysis (GO:0042730) | 6.16019851 |
| 25 | oxidative demethylation (GO:0070989) | 6.09097317 |
| 26 | tricarboxylic acid metabolic process (GO:0072350) | 6.07842429 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.95162094 |
| 28 | excretion (GO:0007588) | 5.90830411 |
| 29 | glutathione biosynthetic process (GO:0006750) | 5.83659002 |
| 30 | blood coagulation, intrinsic pathway (GO:0007597) | 5.77953267 |
| 31 | bile acid biosynthetic process (GO:0006699) | 5.76663665 |
| 32 | phenylpropanoid metabolic process (GO:0009698) | 5.68465574 |
| 33 | toxin transport (GO:1901998) | 5.64273052 |
| 34 | urea cycle (GO:0000050) | 5.60411415 |
| 35 | negative regulation of sterol transport (GO:0032372) | 5.57008603 |
| 36 | negative regulation of cholesterol transport (GO:0032375) | 5.57008603 |
| 37 | renal absorption (GO:0070293) | 5.55972812 |
| 38 | cellular glucuronidation (GO:0052695) | 5.55844240 |
| 39 | aspartate family amino acid catabolic process (GO:0009068) | 5.50288561 |
| 40 | short-chain fatty acid metabolic process (GO:0046459) | 5.40358567 |
| 41 | vitamin D metabolic process (GO:0042359) | 5.38283242 |
| 42 | trivalent inorganic anion homeostasis (GO:0072506) | 5.29679778 |
| 43 | phosphate ion homeostasis (GO:0055062) | 5.29679778 |
| 44 | glucuronate metabolic process (GO:0019585) | 5.28006182 |
| 45 | uronic acid metabolic process (GO:0006063) | 5.28006182 |
| 46 | * serine family amino acid catabolic process (GO:0009071) | 5.19310241 |
| 47 | amino-acid betaine transport (GO:0015838) | 5.14102605 |
| 48 | carnitine transport (GO:0015879) | 5.14102605 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 5.13027444 |
| 50 | bile acid metabolic process (GO:0008206) | 5.13000699 |
| 51 | metanephric nephron tubule development (GO:0072234) | 5.07226790 |
| 52 | metanephric tubule development (GO:0072170) | 5.07226790 |
| 53 | glycine metabolic process (GO:0006544) | 5.05286484 |
| 54 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.99909138 |
| 55 | ethanol metabolic process (GO:0006067) | 4.94308881 |
| 56 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86478334 |
| 57 | bile acid and bile salt transport (GO:0015721) | 4.77979879 |
| 58 | L-phenylalanine metabolic process (GO:0006558) | 4.76491599 |
| 59 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.76491599 |
| 60 | regulation of plasminogen activation (GO:0010755) | 4.76066249 |
| 61 | tryptophan catabolic process (GO:0006569) | 4.73415914 |
| 62 | indole-containing compound catabolic process (GO:0042436) | 4.73415914 |
| 63 | indolalkylamine catabolic process (GO:0046218) | 4.73415914 |
| 64 | valine metabolic process (GO:0006573) | 4.71624775 |
| 65 | cellular modified amino acid catabolic process (GO:0042219) | 4.70478881 |
| 66 | glycoside metabolic process (GO:0016137) | 4.67911391 |
| 67 | modified amino acid transport (GO:0072337) | 4.67173515 |
| 68 | aromatic amino acid family catabolic process (GO:0009074) | 4.65849366 |
| 69 | peptide biosynthetic process (GO:0043043) | 4.65665941 |
| 70 | alkaloid metabolic process (GO:0009820) | 4.65096435 |
| 71 | metanephric nephron epithelium development (GO:0072243) | 4.64101412 |
| 72 | homocysteine metabolic process (GO:0050667) | 4.62099405 |
| 73 | triglyceride homeostasis (GO:0070328) | 4.60273973 |
| 74 | acylglycerol homeostasis (GO:0055090) | 4.60273973 |
| 75 | negative regulation of blood coagulation (GO:0030195) | 4.55753748 |
| 76 | negative regulation of hemostasis (GO:1900047) | 4.55753748 |
| 77 | fructose metabolic process (GO:0006000) | 4.50998387 |
| 78 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.49240711 |
| 79 | L-phenylalanine catabolic process (GO:0006559) | 4.49240711 |
| 80 | protein activation cascade (GO:0072376) | 4.45671274 |
| 81 | tryptophan metabolic process (GO:0006568) | 4.44223874 |
| 82 | amino-acid betaine metabolic process (GO:0006577) | 4.39172758 |
| 83 | 2-oxoglutarate metabolic process (GO:0006103) | 4.38824670 |
| 84 | fatty acid beta-oxidation (GO:0006635) | 4.32460444 |
| 85 | metanephric epithelium development (GO:0072207) | 4.27374950 |
| 86 | phospholipid efflux (GO:0033700) | 4.26901354 |
| 87 | imidazole-containing compound metabolic process (GO:0052803) | 4.25491471 |
| 88 | S-adenosylmethionine metabolic process (GO:0046500) | 4.25041747 |
| 89 | oligosaccharide catabolic process (GO:0009313) | 4.24115620 |
| 90 | branched-chain amino acid catabolic process (GO:0009083) | 4.21753175 |
| 91 | peptide catabolic process (GO:0043171) | 4.20894319 |
| 92 | protein-lipid complex remodeling (GO:0034368) | 4.15192619 |
| 93 | macromolecular complex remodeling (GO:0034367) | 4.15192619 |
| 94 | plasma lipoprotein particle remodeling (GO:0034369) | 4.15192619 |
| 95 | nephron tubule development (GO:0072080) | 4.10390704 |
| 96 | negative regulation of coagulation (GO:0050819) | 4.09268735 |
| 97 | complement activation (GO:0006956) | 4.08873139 |
| 98 | tyrosine metabolic process (GO:0006570) | 4.07630284 |
| 99 | * branched-chain amino acid metabolic process (GO:0009081) | 4.07570501 |
| 100 | negative regulation of wound healing (GO:0061045) | 4.06858549 |
| 101 | carnitine metabolic process (GO:0009437) | 4.06541463 |
| 102 | high-density lipoprotein particle remodeling (GO:0034375) | 4.06330429 |
| 103 | steroid catabolic process (GO:0006706) | 4.06292460 |
| 104 | acetyl-CoA metabolic process (GO:0006084) | 4.00397039 |
| 105 | regulation of cholesterol esterification (GO:0010872) | 3.99671862 |
| 106 | complement activation, classical pathway (GO:0006958) | 3.96996628 |
| 107 | fatty acid oxidation (GO:0019395) | 3.96748660 |
| 108 | glutathione metabolic process (GO:0006749) | 3.94600276 |
| 109 | cholesterol efflux (GO:0033344) | 3.90792276 |
| 110 | response to phenylpropanoid (GO:0080184) | 3.90788051 |
| 111 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.90444505 |
| 112 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.90444505 |
| 113 | lipid oxidation (GO:0034440) | 3.90357022 |
| 114 | negative regulation of lipase activity (GO:0060192) | 3.89645124 |
| 115 | sodium-independent organic anion transport (GO:0043252) | 3.88569722 |
| 116 | arginine metabolic process (GO:0006525) | 3.86718698 |
| 117 | hormone catabolic process (GO:0042447) | 3.86714978 |
| 118 | glutamate metabolic process (GO:0006536) | 3.84492330 |
| 119 | cellular ketone body metabolic process (GO:0046950) | 3.83841562 |
| 120 | regulation of humoral immune response (GO:0002920) | 3.83566630 |
| 121 | sulfur amino acid catabolic process (GO:0000098) | 3.82814259 |
| 122 | vitamin transport (GO:0051180) | 3.82347789 |
| 123 | NADH metabolic process (GO:0006734) | 3.79775637 |
| 124 | positive regulation of hemostasis (GO:1900048) | 3.78833411 |
| 125 | positive regulation of blood coagulation (GO:0030194) | 3.78833411 |
| 126 | negative regulation of protein activation cascade (GO:2000258) | 3.77937920 |
| 127 | acute-phase response (GO:0006953) | 3.77829782 |
| 128 | response to parathyroid hormone (GO:0071107) | 3.76909382 |
| 129 | reverse cholesterol transport (GO:0043691) | 3.74567035 |
| 130 | indole-containing compound metabolic process (GO:0042430) | 3.73980728 |
| 131 | serine family amino acid biosynthetic process (GO:0009070) | 3.66064952 |
| 132 | response to growth hormone (GO:0060416) | 3.63233594 |
| 133 | heme transport (GO:0015886) | 3.63164820 |
| 134 | renal tubule development (GO:0061326) | 3.61620408 |
| 135 | glutathione derivative biosynthetic process (GO:1901687) | 3.60294684 |
| 136 | glutathione derivative metabolic process (GO:1901685) | 3.60294684 |
| 137 | sulfur compound transport (GO:0072348) | 3.59130107 |
| 138 | * serine family amino acid metabolic process (GO:0009069) | 3.59040808 |
| 139 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.58999698 |
| 140 | beta-amyloid metabolic process (GO:0050435) | 3.56660965 |
| 141 | aldehyde catabolic process (GO:0046185) | 3.52460416 |
| 142 | * cellular amino acid catabolic process (GO:0009063) | 3.52100122 |
| 143 | fatty acid catabolic process (GO:0009062) | 3.50973960 |
| 144 | positive regulation of coagulation (GO:0050820) | 3.47667725 |
| 145 | aromatic amino acid family metabolic process (GO:0009072) | 3.47085074 |
| 146 | polyol transport (GO:0015791) | 3.44221647 |
| 147 | biotin metabolic process (GO:0006768) | 3.42919040 |
| 148 | regulation of lipoprotein particle clearance (GO:0010984) | 3.41606295 |
| 149 | * proline metabolic process (GO:0006560) | 3.39841471 |
| 150 | kynurenine metabolic process (GO:0070189) | 3.39170976 |
| 151 | flavonoid metabolic process (GO:0009812) | 3.38443507 |
| 152 | xenobiotic metabolic process (GO:0006805) | 3.35624812 |
| 153 | negative regulation of complement activation (GO:0045916) | 3.35145559 |
| 154 | nephron epithelium morphogenesis (GO:0072088) | 3.35087366 |
| 155 | nephron tubule morphogenesis (GO:0072078) | 3.35087366 |
| 156 | sodium ion transport (GO:0006814) | 3.34009376 |
| 157 | drug metabolic process (GO:0017144) | 3.32414409 |
| 158 | indolalkylamine metabolic process (GO:0006586) | 3.29333005 |
| 159 | monocarboxylic acid catabolic process (GO:0072329) | 3.27676654 |
| 160 | cytolysis (GO:0019835) | 3.27674416 |
| 161 | ketone body metabolic process (GO:1902224) | 3.27365068 |
| 162 | nephron epithelium development (GO:0072009) | 3.24536296 |
| 163 | * alpha-amino acid catabolic process (GO:1901606) | 3.24240848 |
| 164 | * organic acid catabolic process (GO:0016054) | 3.23588097 |
| 165 | * carboxylic acid catabolic process (GO:0046395) | 3.23588097 |
| 166 | opsonization (GO:0008228) | 3.23280441 |
| 167 | cofactor catabolic process (GO:0051187) | 3.22772625 |
| 168 | response to magnesium ion (GO:0032026) | 3.22302183 |
| 169 | L-ascorbic acid metabolic process (GO:0019852) | 3.22029836 |
| 170 | * glyoxylate metabolic process (GO:0046487) | 3.19847195 |
| 171 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.19393166 |
| 172 | aminoglycoside antibiotic metabolic process (GO:0030647) | 10.9688013 |
| 173 | urate metabolic process (GO:0046415) | 10.6940644 |
| 174 | drug transmembrane transport (GO:0006855) | 10.6911779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.75557653 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.73316296 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.89157711 |
| 4 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.48717742 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.44898770 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.33877214 |
| 7 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.24406743 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.05449801 |
| 9 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.77154850 |
| 10 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.74850451 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.35698924 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.31081409 |
| 13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.24342452 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.20499257 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.13707165 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.12517260 |
| 17 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.12010712 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.06113773 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.02139210 |
| 20 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.95148457 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.92775173 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.87916600 |
| 23 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.82417962 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.80656228 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.75648957 |
| 26 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.75597712 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.72976849 |
| 28 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.69159076 |
| 29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.69137601 |
| 30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.63454707 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.56556251 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.55585567 |
| 33 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.51773082 |
| 34 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.49916980 |
| 35 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.44396342 |
| 36 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.39976044 |
| 37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39119542 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34997428 |
| 39 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.34212110 |
| 40 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.34031490 |
| 41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.32975142 |
| 42 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31921296 |
| 43 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.30465946 |
| 44 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.27388222 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.26377064 |
| 46 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24619069 |
| 47 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.23508184 |
| 48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22227515 |
| 49 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22069487 |
| 50 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19619227 |
| 51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.19452126 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19155076 |
| 53 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18728551 |
| 54 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.17181309 |
| 55 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.16316747 |
| 56 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.15812199 |
| 57 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.14451936 |
| 58 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13633862 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12075948 |
| 60 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11015555 |
| 61 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.08805300 |
| 62 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.07992645 |
| 63 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07697949 |
| 64 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.05529926 |
| 65 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.05239088 |
| 66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04671866 |
| 67 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.04146816 |
| 68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02294597 |
| 69 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.01121023 |
| 70 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.00789005 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.00258169 |
| 72 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99003106 |
| 73 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98808960 |
| 74 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98718733 |
| 75 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98366458 |
| 76 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.96717667 |
| 77 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.96598076 |
| 78 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96426656 |
| 79 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96426656 |
| 80 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.96215057 |
| 81 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.95510059 |
| 82 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94773661 |
| 83 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.94706268 |
| 84 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94343998 |
| 85 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93423287 |
| 86 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93338691 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92379978 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90333051 |
| 89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89964744 |
| 90 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89537405 |
| 91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88842091 |
| 92 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.88618442 |
| 93 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.87573749 |
| 94 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85462312 |
| 95 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.84489736 |
| 96 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.84489736 |
| 97 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83864812 |
| 98 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.83562217 |
| 99 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.83309130 |
| 100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.82878290 |
| 101 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.82692163 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82579838 |
| 103 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.82424662 |
| 104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.82308937 |
| 105 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.82246937 |
| 106 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.81587472 |
| 107 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81540945 |
| 108 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81320217 |
| 109 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.81176586 |
| 110 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.81084944 |
| 111 | * P68_20966046_ChIP-Seq_HELA_Human | 0.80372360 |
| 112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80085201 |
| 113 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.80024157 |
| 114 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.79567738 |
| 115 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.79523034 |
| 116 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.79244803 |
| 117 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79155124 |
| 118 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.78976017 |
| 119 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78946301 |
| 120 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78446355 |
| 121 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.78373930 |
| 122 | SA1_27219007_Chip-Seq_Bcells_Human | 0.78289476 |
| 123 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78130092 |
| 124 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.77930431 |
| 125 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.77860594 |
| 126 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.77806165 |
| 127 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.77625132 |
| 128 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.77517540 |
| 129 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.76848450 |
| 130 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.76654932 |
| 131 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.75896763 |
| 132 | CBP_21632823_ChIP-Seq_H3396_Human | 0.75765217 |
| 133 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.75491163 |
| 134 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75272832 |
| 135 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75238843 |
| 136 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74840432 |
| 137 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.74718022 |
| 138 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.74564993 |
| 139 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.74391197 |
| 140 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.74375271 |
| 141 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.73986876 |
| 142 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.73885709 |
| 143 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.73861970 |
| 144 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.73503648 |
| 145 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.73004671 |
| 146 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.72992662 |
| 147 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.72277551 |
| 148 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.71714137 |
| 149 | STAT3_23295773_ChIP-Seq_U87_Human | 0.71606669 |
| 150 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.71196428 |
| 151 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.71102848 |
| 152 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.71003690 |
| 153 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.70569682 |
| 154 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.70526790 |
| 155 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70449507 |
| 156 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.70224829 |
| 157 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.69518298 |
| 158 | AR_19668381_ChIP-Seq_PC3_Human | 0.67807779 |
| 159 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.67693217 |
| 160 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.67567050 |
| 161 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.67363281 |
| 162 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.66770546 |
| 163 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.66630056 |
| 164 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.66274691 |
| 165 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.66147539 |
| 166 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.65743232 |
| 167 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.65347232 |
| 168 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.64902883 |
| 169 | TCF4_23295773_ChIP-Seq_U87_Human | 0.64794444 |
| 170 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.64583604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.82304040 |
| 2 | MP0004043_abnormal_pH_regulation | 6.47061598 |
| 3 | MP0004019_abnormal_vitamin_homeostasis | 5.34517930 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.82334234 |
| 5 | * MP0005332_abnormal_amino_acid | 4.71812610 |
| 6 | MP0009643_abnormal_urine_homeostasis | 3.89568738 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.88178457 |
| 8 | MP0001765_abnormal_ion_homeostasis | 3.76733718 |
| 9 | MP0003868_abnormal_feces_composition | 3.64898954 |
| 10 | MP0003195_calcinosis | 3.58755595 |
| 11 | MP0005377_hearing/vestibular/ear_phenot | 3.11868357 |
| 12 | MP0003878_abnormal_ear_physiology | 3.11868357 |
| 13 | MP0005636_abnormal_mineral_homeostasis | 3.05995203 |
| 14 | MP0001756_abnormal_urination | 2.98395322 |
| 15 | MP0002136_abnormal_kidney_physiology | 2.90991590 |
| 16 | MP0009697_abnormal_copulation | 2.90601097 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.71884270 |
| 18 | MP0001958_emphysema | 2.56429950 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.40351446 |
| 20 | MP0003252_abnormal_bile_duct | 2.19245397 |
| 21 | MP0005365_abnormal_bile_salt | 2.18733003 |
| 22 | MP0005085_abnormal_gallbladder_physiolo | 2.12316899 |
| 23 | MP0004885_abnormal_endolymph | 2.03466995 |
| 24 | MP0009840_abnormal_foam_cell | 1.83758671 |
| 25 | MP0000538_abnormal_urinary_bladder | 1.82873707 |
| 26 | MP0003186_abnormal_redox_activity | 1.78907932 |
| 27 | MP0005423_abnormal_somatic_nervous | 1.64830465 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61174043 |
| 29 | MP0003880_abnormal_central_pattern | 1.57865826 |
| 30 | MP0003283_abnormal_digestive_organ | 1.49917143 |
| 31 | MP0008961_abnormal_basal_metabolism | 1.45479288 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.33208493 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.32851077 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.32494643 |
| 35 | MP0004147_increased_porphyrin_level | 1.31765160 |
| 36 | MP0005670_abnormal_white_adipose | 1.30349449 |
| 37 | MP0002089_abnormal_postnatal_growth/wei | 1.27035723 |
| 38 | MP0005451_abnormal_body_composition | 1.26292704 |
| 39 | MP0003690_abnormal_glial_cell | 1.24426003 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.23240142 |
| 41 | MP0002928_abnormal_bile_duct | 1.22949656 |
| 42 | MP0002168_other_aberrant_phenotype | 1.22675994 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 1.21173797 |
| 44 | MP0002064_seizures | 1.20515426 |
| 45 | MP0004859_abnormal_synaptic_plasticity | 1.13633064 |
| 46 | * MP0009745_abnormal_behavioral_response | 1.12385536 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.08954484 |
| 48 | MP0002272_abnormal_nervous_system | 1.05621305 |
| 49 | MP0000604_amyloidosis | 1.03793087 |
| 50 | MP0001440_abnormal_grooming_behavior | 1.03707464 |
| 51 | MP0010368_abnormal_lymphatic_system | 1.03507224 |
| 52 | MP0002135_abnormal_kidney_morphology | 1.00417962 |
| 53 | MP0005535_abnormal_body_temperature | 0.99867210 |
| 54 | MP0000230_abnormal_systemic_arterial | 0.98036676 |
| 55 | MP0000371_diluted_coat_color | 0.96492025 |
| 56 | MP0005187_abnormal_penis_morphology | 0.95796352 |
| 57 | * MP0003635_abnormal_synaptic_transmissio | 0.94504603 |
| 58 | MP0008874_decreased_physiological_sensi | 0.93523464 |
| 59 | MP0003806_abnormal_nucleotide_metabolis | 0.92850651 |
| 60 | MP0004270_analgesia | 0.92536404 |
| 61 | MP0002735_abnormal_chemical_nociception | 0.92227396 |
| 62 | MP0002896_abnormal_bone_mineralization | 0.91874959 |
| 63 | MP0001666_abnormal_nutrient_absorption | 0.91813682 |
| 64 | MP0001764_abnormal_homeostasis | 0.91409547 |
| 65 | MP0004264_abnormal_extraembryonic_tissu | 0.90995275 |
| 66 | MP0003638_abnormal_response/metabolism_ | 0.90020038 |
| 67 | MP0002063_abnormal_learning/memory/cond | 0.89619181 |
| 68 | MP0001485_abnormal_pinna_reflex | 0.88388662 |
| 69 | MP0005666_abnormal_adipose_tissue | 0.88201799 |
| 70 | MP0001501_abnormal_sleep_pattern | 0.87016427 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 0.81178178 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 0.78938300 |
| 73 | MP0005408_hypopigmentation | 0.78084044 |
| 74 | MP0004233_abnormal_muscle_weight | 0.77793908 |
| 75 | MP0003011_delayed_dark_adaptation | 0.76786446 |
| 76 | MP0002796_impaired_skin_barrier | 0.76369210 |
| 77 | MP0001486_abnormal_startle_reflex | 0.75913083 |
| 78 | MP0009046_muscle_twitch | 0.75428959 |
| 79 | MP0003646_muscle_fatigue | 0.75003069 |
| 80 | MP0004742_abnormal_vestibular_system | 0.73178665 |
| 81 | MP0001968_abnormal_touch/_nociception | 0.72358942 |
| 82 | MP0009764_decreased_sensitivity_to | 0.70202283 |
| 83 | MP0002572_abnormal_emotion/affect_behav | 0.69732713 |
| 84 | MP0005376_homeostasis/metabolism_phenot | 0.68720455 |
| 85 | MP0009053_abnormal_anal_canal | 0.67822552 |
| 86 | MP0001986_abnormal_taste_sensitivity | 0.67504287 |
| 87 | MP0001915_intracranial_hemorrhage | 0.66764399 |
| 88 | MP0005266_abnormal_metabolism | 0.66150677 |
| 89 | * MP0009642_abnormal_blood_homeostasis | 0.65807003 |
| 90 | MP0000747_muscle_weakness | 0.65516115 |
| 91 | MP0005395_other_phenotype | 0.65474243 |
| 92 | MP0000920_abnormal_myelination | 0.64219877 |
| 93 | MP0002736_abnormal_nociception_after | 0.63855887 |
| 94 | MP0002734_abnormal_mechanical_nocicepti | 0.62811517 |
| 95 | MP0003631_nervous_system_phenotype | 0.62370615 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.61823005 |
| 97 | MP0001502_abnormal_circadian_rhythm | 0.61207300 |
| 98 | MP0002249_abnormal_larynx_morphology | 0.60769616 |
| 99 | MP0004130_abnormal_muscle_cell | 0.60400345 |
| 100 | MP0008569_lethality_at_weaning | 0.59641233 |
| 101 | MP0002282_abnormal_trachea_morphology | 0.59609884 |
| 102 | MP0001661_extended_life_span | 0.58339502 |
| 103 | MP0003879_abnormal_hair_cell | 0.57819635 |
| 104 | MP0005501_abnormal_skin_physiology | 0.56249541 |
| 105 | MP0003959_abnormal_lean_body | 0.55528506 |
| 106 | MP0003632_abnormal_nervous_system | 0.55142709 |
| 107 | MP0004142_abnormal_muscle_tone | 0.54719142 |
| 108 | MP0009763_increased_sensitivity_to | 0.54495918 |
| 109 | MP0002132_abnormal_respiratory_system | 0.54426464 |
| 110 | MP0002090_abnormal_vision | 0.53728804 |
| 111 | MP0002115_abnormal_skeleton_extremities | 0.51920961 |
| 112 | MP0000609_abnormal_liver_physiology | 0.51903697 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.51253610 |
| 114 | MP0004924_abnormal_behavior | 0.51253610 |
| 115 | MP0001984_abnormal_olfaction | 0.50984884 |
| 116 | MP0000566_synostosis | 0.50860126 |
| 117 | MP0005220_abnormal_exocrine_pancreas | 0.49726602 |
| 118 | MP0003953_abnormal_hormone_level | 0.49464192 |
| 119 | MP0005551_abnormal_eye_electrophysiolog | 0.48534829 |
| 120 | MP0010329_abnormal_lipoprotein_level | 0.48268978 |
| 121 | MP0005448_abnormal_energy_balance | 0.47661757 |
| 122 | MP0002069_abnormal_eating/drinking_beha | 0.46646669 |
| 123 | MP0002998_abnormal_bone_remodeling | 0.46008229 |
| 124 | MP0005646_abnormal_pituitary_gland | 0.45814427 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.45418633 |
| 126 | * MP0002066_abnormal_motor_capabilities/c | 0.45227218 |
| 127 | MP0002822_catalepsy | 0.44481609 |
| 128 | MP0000598_abnormal_liver_morphology | 0.44374628 |
| 129 | MP0001963_abnormal_hearing_physiology | 0.43635210 |
| 130 | MP0006035_abnormal_mitochondrial_morpho | 0.43006195 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.42291315 |
| 132 | MP0000678_abnormal_parathyroid_gland | 0.41838817 |
| 133 | MP0002078_abnormal_glucose_homeostasis | 0.40858872 |
| 134 | MP0001731_abnormal_postnatal_growth | 0.40520631 |
| 135 | MP0008469_abnormal_protein_level | 0.39293139 |
| 136 | MP0005165_increased_susceptibility_to | 0.38591944 |
| 137 | MP0002098_abnormal_vibrissa_morphology | 0.38061885 |
| 138 | MP0003795_abnormal_bone_structure | 0.37990434 |
| 139 | MP0000163_abnormal_cartilage_morphology | 0.36943825 |
| 140 | MP0002067_abnormal_sensory_capabilities | 0.36418663 |
| 141 | MP0003329_amyloid_beta_deposits | 0.36160838 |
| 142 | MP0003633_abnormal_nervous_system | 0.35756459 |
| 143 | MP0001663_abnormal_digestive_system | 0.35621159 |
| 144 | MP0001293_anophthalmia | 0.35056742 |
| 145 | MP0002971_abnormal_brown_adipose | 0.32103736 |
| 146 | MP0009278_abnormal_bone_marrow | 0.31955929 |
| 147 | MP0005167_abnormal_blood-brain_barrier | 0.31816999 |
| 148 | MP0005375_adipose_tissue_phenotype | 0.30133261 |
| 149 | MP0004484_altered_response_of | 0.29003406 |
| 150 | MP0003075_altered_response_to | 0.28930608 |
| 151 | MP0000367_abnormal_coat/_hair | 0.28788656 |
| 152 | MP0008872_abnormal_physiological_respon | 0.26967362 |
| 153 | MP0005381_digestive/alimentary_phenotyp | 0.26559619 |
| 154 | MP0002075_abnormal_coat/hair_pigmentati | 0.26089918 |
| 155 | MP0004858_abnormal_nervous_system | 0.26005906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 8.66032820 |
| 2 | Complement deficiency (HP:0004431) | 7.94181817 |
| 3 | Increased circulating renin level (HP:0000848) | 7.54666785 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 7.35595179 |
| 5 | Metabolic alkalosis (HP:0200114) | 7.26059301 |
| 6 | Hypokalemic alkalosis (HP:0001949) | 7.09753593 |
| 7 | Gout (HP:0001997) | 6.91910506 |
| 8 | Hypomagnesemia (HP:0002917) | 6.82118842 |
| 9 | Polyuria (HP:0000103) | 6.64844106 |
| 10 | Hyperactive renin-angiotensin system (HP:0000841) | 6.59424278 |
| 11 | Abnormality of complement system (HP:0005339) | 6.24461354 |
| 12 | Abnormal urine output (HP:0012590) | 6.24391289 |
| 13 | Abnormality of chloride homeostasis (HP:0011422) | 6.14572103 |
| 14 | Abnormality of renal excretion (HP:0011036) | 6.00003950 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 5.90927657 |
| 16 | Joint hemorrhage (HP:0005261) | 5.84132910 |
| 17 | Abnormality of magnesium homeostasis (HP:0004921) | 5.77171086 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 5.55309721 |
| 19 | Abnormal drinking behavior (HP:0030082) | 5.40126163 |
| 20 | Polydipsia (HP:0001959) | 5.40126163 |
| 21 | Proximal tubulopathy (HP:0000114) | 5.38591127 |
| 22 | Conjugated hyperbilirubinemia (HP:0002908) | 5.33735239 |
| 23 | Increased purine levels (HP:0004368) | 5.10736800 |
| 24 | Hyperuricemia (HP:0002149) | 5.10736800 |
| 25 | Intrahepatic cholestasis (HP:0001406) | 5.01327613 |
| 26 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.83410342 |
| 27 | Hyperglycinuria (HP:0003108) | 4.79456444 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.79268596 |
| 29 | Xanthomatosis (HP:0000991) | 4.76898264 |
| 30 | Renal salt wasting (HP:0000127) | 4.71222979 |
| 31 | Alkalosis (HP:0001948) | 4.68994306 |
| 32 | Abnormality of renin-angiotensin system (HP:0000847) | 4.67989577 |
| 33 | Tetany (HP:0001281) | 4.60239958 |
| 34 | Glomerulonephritis (HP:0000099) | 4.57776163 |
| 35 | Hyperaldosteronism (HP:0000859) | 4.57610493 |
| 36 | Abnormality of purine metabolism (HP:0004352) | 4.48532204 |
| 37 | Hypolipoproteinemia (HP:0010981) | 4.26859649 |
| 38 | Generalized aminoaciduria (HP:0002909) | 4.20671487 |
| 39 | Hypercalciuria (HP:0002150) | 4.18804911 |
| 40 | Abnormality of glycine metabolism (HP:0010895) | 3.83484009 |
| 41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.83484009 |
| 42 | Abnormality of the common coagulation pathway (HP:0010990) | 3.79555282 |
| 43 | Ketoacidosis (HP:0001993) | 3.79108487 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.72631670 |
| 45 | Renal tubular acidosis (HP:0001947) | 3.65489498 |
| 46 | Abnormality of urine glucose concentration (HP:0011016) | 3.64634728 |
| 47 | Glycosuria (HP:0003076) | 3.64634728 |
| 48 | Hypokalemia (HP:0002900) | 3.59870332 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.57268537 |
| 50 | Abnormality of the intrinsic pathway (HP:0010989) | 3.43576660 |
| 51 | Abnormality of nucleobase metabolism (HP:0010932) | 3.28843929 |
| 52 | Abnormality of proline metabolism (HP:0010907) | 3.21933524 |
| 53 | Hydroxyprolinuria (HP:0003080) | 3.21933524 |
| 54 | Ketosis (HP:0001946) | 3.21878439 |
| 55 | Hyperphosphaturia (HP:0003109) | 3.18101641 |
| 56 | Nephritis (HP:0000123) | 3.14929165 |
| 57 | Delayed epiphyseal ossification (HP:0002663) | 3.14487497 |
| 58 | Spontaneous abortion (HP:0005268) | 3.12264365 |
| 59 | Nephrocalcinosis (HP:0000121) | 3.06895320 |
| 60 | Fat malabsorption (HP:0002630) | 3.05289791 |
| 61 | Hypoalphalipoproteinemia (HP:0003233) | 3.04992356 |
| 62 | Abnormal urine phosphate concentration (HP:0012599) | 3.04968626 |
| 63 | Abnormality of potassium homeostasis (HP:0011042) | 3.01191287 |
| 64 | Osteomalacia (HP:0002749) | 2.97595454 |
| 65 | Cholecystitis (HP:0001082) | 2.84722548 |
| 66 | Abnormal gallbladder physiology (HP:0012438) | 2.84722548 |
| 67 | Nephrolithiasis (HP:0000787) | 2.82079676 |
| 68 | Vascular calcification (HP:0004934) | 2.78033156 |
| 69 | Metaphyseal cupping (HP:0003021) | 2.73261124 |
| 70 | Delayed CNS myelination (HP:0002188) | 2.72500261 |
| 71 | Hypophosphatemia (HP:0002148) | 2.72401949 |
| 72 | Reduced antithrombin III activity (HP:0001976) | 2.72377541 |
| 73 | Epidermoid cyst (HP:0200040) | 2.67984233 |
| 74 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.65701755 |
| 75 | Widely patent fontanelles and sutures (HP:0004492) | 2.62430796 |
| 76 | Hyperglycinemia (HP:0002154) | 2.62068281 |
| 77 | Rickets (HP:0002748) | 2.61897425 |
| 78 | Steatorrhea (HP:0002570) | 2.61079362 |
| 79 | Abnormality of methionine metabolism (HP:0010901) | 2.60547036 |
| 80 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.58883371 |
| 81 | Hypercholesterolemia (HP:0003124) | 2.56710983 |
| 82 | Abnormality of serum amino acid levels (HP:0003112) | 2.53072080 |
| 83 | Fair hair (HP:0002286) | 2.52510815 |
| 84 | Vacuolated lymphocytes (HP:0001922) | 2.48936436 |
| 85 | Dehydration (HP:0001944) | 2.46917396 |
| 86 | Cardiovascular calcification (HP:0011915) | 2.44590082 |
| 87 | Abnormality of the Achilles tendon (HP:0005109) | 2.42371226 |
| 88 | Abnormality of sodium homeostasis (HP:0010931) | 2.40917415 |
| 89 | Menorrhagia (HP:0000132) | 2.37981669 |
| 90 | Purpura (HP:0000979) | 2.37053262 |
| 91 | Confusion (HP:0001289) | 2.36588519 |
| 92 | Pulmonary embolism (HP:0002204) | 2.36199912 |
| 93 | Hyponatremia (HP:0002902) | 2.36038758 |
| 94 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.35817792 |
| 95 | Hyperammonemia (HP:0001987) | 2.35632557 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.33237939 |
| 97 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.30627702 |
| 98 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.30427849 |
| 99 | Mitral stenosis (HP:0001718) | 2.30350043 |
| 100 | Myokymia (HP:0002411) | 2.27412036 |
| 101 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.27176876 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 2.27176876 |
| 103 | Malnutrition (HP:0004395) | 2.26835925 |
| 104 | Neonatal hypoglycemia (HP:0001998) | 2.24474857 |
| 105 | Vomiting (HP:0002013) | 2.20533504 |
| 106 | Metabolic acidosis (HP:0001942) | 2.20521875 |
| 107 | Abnormality of renal resorption (HP:0011038) | 2.20466652 |
| 108 | Gingival bleeding (HP:0000225) | 2.19107111 |
| 109 | Adrenal overactivity (HP:0002717) | 2.18063195 |
| 110 | Renal tubular dysfunction (HP:0000124) | 2.15908370 |
| 111 | Hyperbilirubinemia (HP:0002904) | 2.15553082 |
| 112 | Enlarged kidneys (HP:0000105) | 2.14273217 |
| 113 | Arthropathy (HP:0003040) | 2.09159646 |
| 114 | Cholelithiasis (HP:0001081) | 2.08403567 |
| 115 | Bile duct proliferation (HP:0001408) | 2.07635662 |
| 116 | Abnormal biliary tract physiology (HP:0012439) | 2.07635662 |
| 117 | Abnormal tarsal ossification (HP:0008369) | 2.06416329 |
| 118 | Thin bony cortex (HP:0002753) | 2.05816678 |
| 119 | Atrioventricular block (HP:0001678) | 2.03777710 |
| 120 | Methylmalonic aciduria (HP:0012120) | 2.02779259 |
| 121 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.2976122 |
| 122 | Deep venous thrombosis (HP:0002625) | 10.2556755 |
| 123 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.99694146 |
| 124 | Thrombophlebitis (HP:0004418) | 1.99463139 |
| 125 | Abnormality of vitamin metabolism (HP:0100508) | 1.99333232 |
| 126 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.97958017 |
| 127 | Lethargy (HP:0001254) | 1.96996358 |
| 128 | Abnormal gallbladder morphology (HP:0012437) | 1.94922073 |
| 129 | Abnormality of the costochondral junction (HP:0000919) | 1.93067047 |
| 130 | Tubular atrophy (HP:0000092) | 1.90420966 |
| 131 | Status epilepticus (HP:0002133) | 1.90137263 |
| 132 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.87242864 |
| 133 | Dysostosis multiplex (HP:0000943) | 1.84407238 |
| 134 | Hepatocellular carcinoma (HP:0001402) | 1.83083148 |
| 135 | Mucopolysacchariduria (HP:0008155) | 1.81744079 |
| 136 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81744079 |
| 137 | Torticollis (HP:0000473) | 1.81562790 |
| 138 | Chondrocalcinosis (HP:0000934) | 1.80975289 |
| 139 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79750064 |
| 140 | Potter facies (HP:0002009) | 1.78607893 |
| 141 | Facial shape deformation (HP:0011334) | 1.78607893 |
| 142 | Action tremor (HP:0002345) | 1.78201592 |
| 143 | Irritability (HP:0000737) | 1.77709176 |
| 144 | Decreased circulating renin level (HP:0003351) | 1.77159743 |
| 145 | Generalized hypopigmentation of hair (HP:0011358) | 1.75985173 |
| 146 | Tubulointerstitial fibrosis (HP:0005576) | 1.75464454 |
| 147 | Bicornuate uterus (HP:0000813) | 1.75017798 |
| 148 | Focal motor seizures (HP:0011153) | 1.74977520 |
| 149 | Metaphyseal irregularity (HP:0003025) | 1.74273110 |
| 150 | Lymphangioma (HP:0100764) | 1.74140533 |
| 151 | Elevated alkaline phosphatase (HP:0003155) | 1.70508229 |
| 152 | Abnormality of Sharpey fibers (HP:0100685) | 1.70465489 |
| 153 | Neonatal onset (HP:0003623) | 1.70057604 |
| 154 | Blue irides (HP:0000635) | 1.69707509 |
| 155 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.69391421 |
| 156 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.69391421 |
| 157 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.69391421 |
| 158 | Nausea (HP:0002018) | 1.68963784 |
| 159 | Hypotension (HP:0002615) | 1.68606649 |
| 160 | Bifid scrotum (HP:0000048) | 1.68537148 |
| 161 | Abnormality of carpal bone ossification (HP:0006257) | 1.68069044 |
| 162 | Retinal atrophy (HP:0001105) | 1.64113054 |
| 163 | Abnormality of the lower motor neuron (HP:0002366) | 1.62961523 |
| 164 | Sensorimotor neuropathy (HP:0007141) | 1.62568026 |
| 165 | Skin nodule (HP:0200036) | 1.59360228 |
| 166 | Focal dystonia (HP:0004373) | 1.59187260 |
| 167 | Craniofacial dystonia (HP:0012179) | 1.56665351 |
| 168 | Febrile seizures (HP:0002373) | 1.56392542 |
| 169 | Cerebral edema (HP:0002181) | 1.52744130 |
| 170 | Myocardial infarction (HP:0001658) | 1.51737240 |
| 171 | Gangrene (HP:0100758) | 1.51634425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 8.81857048 |
| 2 | WNK3 | 7.60062001 |
| 3 | OXSR1 | 7.11652779 |
| 4 | STK39 | 3.97080786 |
| 5 | NTRK3 | 3.82904193 |
| 6 | DAPK2 | 3.57709498 |
| 7 | MARK1 | 3.08867489 |
| 8 | BCKDK | 2.83837318 |
| 9 | EPHA4 | 2.70392741 |
| 10 | STK38L | 2.66128174 |
| 11 | WNK1 | 2.28039151 |
| 12 | CAMKK2 | 2.25212865 |
| 13 | PINK1 | 2.19381769 |
| 14 | PIK3CG | 1.99718181 |
| 15 | NTRK2 | 1.97795111 |
| 16 | NEK1 | 1.95768926 |
| 17 | SGK223 | 1.93402441 |
| 18 | SGK494 | 1.93402441 |
| 19 | CAMKK1 | 1.91337667 |
| 20 | MAP3K9 | 1.88294063 |
| 21 | PRPF4B | 1.84281346 |
| 22 | CASK | 1.74813589 |
| 23 | PDK3 | 1.67804756 |
| 24 | PDK4 | 1.67804756 |
| 25 | STK38 | 1.67514828 |
| 26 | PIK3CA | 1.61502250 |
| 27 | ARAF | 1.60849164 |
| 28 | PAK6 | 1.57655755 |
| 29 | MAP3K12 | 1.52474596 |
| 30 | MAPK15 | 1.41147727 |
| 31 | MAP3K4 | 1.40848920 |
| 32 | ERN1 | 1.28979471 |
| 33 | ICK | 1.22793722 |
| 34 | PDK2 | 1.21672439 |
| 35 | GRK5 | 1.17758828 |
| 36 | CAMK2B | 1.16968061 |
| 37 | SGK3 | 1.15711634 |
| 38 | DDR2 | 1.13923564 |
| 39 | MST1R | 1.12363423 |
| 40 | SGK2 | 1.09632193 |
| 41 | DYRK1B | 1.07136928 |
| 42 | GSK3A | 1.01526115 |
| 43 | MAP3K6 | 0.99321215 |
| 44 | DYRK1A | 0.94269990 |
| 45 | MST4 | 0.91995365 |
| 46 | MAP2K7 | 0.91941343 |
| 47 | MARK2 | 0.91223511 |
| 48 | FGFR2 | 0.88449432 |
| 49 | CDK5 | 0.87604912 |
| 50 | KSR2 | 0.87342042 |
| 51 | PRKD2 | 0.86877991 |
| 52 | MAP3K11 | 0.86414746 |
| 53 | RIPK1 | 0.85357138 |
| 54 | ERBB2 | 0.81215568 |
| 55 | CAMK2A | 0.81147413 |
| 56 | SGK1 | 0.81108512 |
| 57 | EPHB1 | 0.78770245 |
| 58 | FGFR4 | 0.73424589 |
| 59 | PRKG1 | 0.73106855 |
| 60 | LATS2 | 0.72629697 |
| 61 | PRKAA1 | 0.70313497 |
| 62 | CAMK2D | 0.69521929 |
| 63 | GRK6 | 0.68828324 |
| 64 | MAPK13 | 0.68765892 |
| 65 | MAPK11 | 0.67114547 |
| 66 | BMX | 0.65962862 |
| 67 | MATK | 0.65125650 |
| 68 | MUSK | 0.63290377 |
| 69 | CSNK1D | 0.60280509 |
| 70 | FRK | 0.60164801 |
| 71 | DAPK3 | 0.59129305 |
| 72 | PTK2 | 0.58869757 |
| 73 | LRRK2 | 0.58435022 |
| 74 | RET | 0.55617051 |
| 75 | RPS6KB1 | 0.55063601 |
| 76 | CSNK1A1 | 0.52817785 |
| 77 | CSNK1G2 | 0.52658900 |
| 78 | MAPK10 | 0.52658816 |
| 79 | SIK1 | 0.52019309 |
| 80 | CDK15 | 0.51579134 |
| 81 | PRKCB | 0.50180974 |
| 82 | CSK | 0.50171082 |
| 83 | IGF1R | 0.49602188 |
| 84 | PRKAA2 | 0.49049560 |
| 85 | TYRO3 | 0.48304618 |
| 86 | LMTK2 | 0.47877818 |
| 87 | PRKCE | 0.46964171 |
| 88 | CDK18 | 0.46301199 |
| 89 | DAPK1 | 0.45766600 |
| 90 | PIM1 | 0.45765921 |
| 91 | CAMK1 | 0.45276845 |
| 92 | MAP3K7 | 0.42527469 |
| 93 | PDGFRA | 0.41217022 |
| 94 | CDK14 | 0.40971760 |
| 95 | JAK1 | 0.40913828 |
| 96 | CDK11A | 0.38399197 |
| 97 | TAOK2 | 0.37747716 |
| 98 | PTK6 | 0.37688726 |
| 99 | FGFR3 | 0.37236534 |
| 100 | PKN1 | 0.36742430 |
| 101 | TIE1 | 0.36286720 |
| 102 | PAK4 | 0.36277282 |
| 103 | PRKCZ | 0.34316396 |
| 104 | PDPK1 | 0.33919034 |
| 105 | PRKCI | 0.30790606 |
| 106 | STK11 | 0.30403964 |
| 107 | MAP3K14 | 0.29530353 |
| 108 | FGR | 0.28173901 |
| 109 | PRKCD | 0.27129803 |
| 110 | UHMK1 | 0.25596245 |
| 111 | PRKACG | 0.25288572 |
| 112 | ABL2 | 0.24592284 |
| 113 | MAP3K3 | 0.24284940 |
| 114 | TGFBR2 | 0.23623556 |
| 115 | TRIB3 | 0.22371849 |
| 116 | PDK1 | 0.21634327 |
| 117 | PHKG2 | 0.21050179 |
| 118 | PHKG1 | 0.21050179 |
| 119 | YES1 | 0.20920855 |
| 120 | IRAK3 | 0.20730424 |
| 121 | IRAK2 | 0.18991075 |
| 122 | MINK1 | 0.18361103 |
| 123 | INSRR | 0.16310115 |
| 124 | CAMK2G | 0.15619947 |
| 125 | PRKCH | 0.15153737 |
| 126 | AKT2 | 0.15042613 |
| 127 | PRKCG | 0.14531381 |
| 128 | PRKACA | 0.14385472 |
| 129 | JAK2 | 0.14377958 |
| 130 | TRPM7 | 0.14146590 |
| 131 | PRKCA | 0.13621096 |
| 132 | CAMK4 | 0.13574521 |
| 133 | PIM2 | 0.11114388 |
| 134 | STK10 | 0.10933737 |
| 135 | PAK3 | 0.10398478 |
| 136 | MET | 0.09037524 |
| 137 | CDC42BPA | 0.08642063 |
| 138 | FER | 0.08418291 |
| 139 | RPS6KA3 | 0.07232280 |
| 140 | INSR | 0.07196213 |
| 141 | RPS6KA1 | 0.07048383 |
| 142 | ERBB4 | 0.06290712 |
| 143 | PTK2B | 0.06288893 |
| 144 | MAP2K4 | 0.06033402 |
| 145 | SIK3 | 0.05969627 |
| 146 | TNK2 | 0.05818664 |
| 147 | MTOR | 0.03277496 |
| 148 | NTRK1 | 0.03113688 |
| 149 | MAPK4 | 0.02745993 |
| 150 | CDK6 | 0.02603010 |
| 151 | MAPK12 | 0.02522428 |
| 152 | SRC | 0.02270452 |
| 153 | ERBB3 | 0.02210058 |
| 154 | SIK2 | 0.02206014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.08887840 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.86351543 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.82426581 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.70913676 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.56808962 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.43202414 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36887015 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.12295850 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.11063736 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.05050806 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.96874486 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.89151396 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.62595546 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.44242431 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.30344615 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16368678 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.15522561 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.15108228 |
| 19 | * Peroxisome_Homo sapiens_hsa04146 | 2.13573909 |
| 20 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.10766016 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.93026707 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87917709 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86819257 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.71357517 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.69897470 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.68714965 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.66640494 |
| 28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.62433383 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.57107800 |
| 30 | Mineral absorption_Homo sapiens_hsa04978 | 1.50365041 |
| 31 | Lysine degradation_Homo sapiens_hsa00310 | 1.45160576 |
| 32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.37040253 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.31168620 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22875835 |
| 35 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.22629340 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21988140 |
| 37 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.20711586 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19237809 |
| 39 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.18651420 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14319273 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10316537 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.08228340 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06574287 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04809457 |
| 45 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04138844 |
| 46 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.02050245 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 1.01672531 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00205780 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98971999 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97048005 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 0.93884447 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92965059 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92929087 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.92899570 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92885674 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.84606246 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.83527899 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81287369 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76820820 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68586272 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67183180 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.64176402 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63354427 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63103551 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60479823 |
| 66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59610940 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58815340 |
| 68 | Nicotine addiction_Homo sapiens_hsa05033 | 0.57058298 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56943150 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.56540276 |
| 71 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55887508 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53293287 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50788829 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50079483 |
| 75 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48975872 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47538501 |
| 77 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46632113 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42582022 |
| 79 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.42498521 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42028066 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41311946 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.35077045 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33489039 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32888012 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.32666348 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.32002418 |
| 87 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.27067164 |
| 88 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.26400371 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.25304820 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23705597 |
| 91 | Parkinsons disease_Homo sapiens_hsa05012 | 0.23264254 |
| 92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.21791418 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.21646617 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.19704031 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17167944 |
| 96 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.16916994 |
| 97 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.16519714 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.15186570 |
| 99 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.14129433 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.14014959 |
| 101 | Cocaine addiction_Homo sapiens_hsa05030 | 0.12741318 |
| 102 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.12731297 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.12003793 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.11468721 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.09841534 |
| 106 | Morphine addiction_Homo sapiens_hsa05032 | 0.09229982 |
| 107 | Insulin secretion_Homo sapiens_hsa04911 | 0.08175990 |
| 108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.07278885 |
| 109 | Circadian entrainment_Homo sapiens_hsa04713 | 0.05733244 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03266935 |
| 111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.02931538 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.02404225 |
| 113 | Long-term potentiation_Homo sapiens_hsa04720 | 0.00933439 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0806139 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0676299 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0620390 |
| 117 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0608187 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0525374 |
| 119 | Taste transduction_Homo sapiens_hsa04742 | -0.0504041 |
| 120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | -0.0443323 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0365273 |
| 122 | Dopaminergic synapse_Homo sapiens_hsa04728 | -0.0334240 |
| 123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0209442 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | -0.0205050 |
| 125 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0142898 |
| 126 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0046355 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0036105 |

